List of works - Ray E Hershberger

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy

scientific article published on 05 September 2019

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia

scientific article published on 7 April 2015

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

scientific article published on June 2013

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee

article by James C Fang et al published 4 May 2015 in Journal of Cardiac Failure

Assessment of LMNA Copy Number Variation in 58 Probands with Dilated Cardiomyopathy ⬇️

scientific article published on October 1, 2011

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

scientific article published on 20 May 2008

ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation

article

Clinical Application of Genetic Testing in Heart Failure.

scientific article published on 23 October 2017

Clinical Genetic Testing for Familial Hypercholesterolemia

scientific article published on 01 August 2018

Clinical Outcomes, Quality of Life, and Cost Outcomes After Cardiac Transplantation

scientific article published on September 1, 1997

Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals ⬇️

scientific article published on November 1, 2010

Considering complexity in the genetic evaluation of dilated cardiomyopathy

scientific article published on 27 October 2020

Dilated cardiomyopathy

scientific article published on 09 May 2019

Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

scientific article published on 30 July 2013

Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity ⬇️

scientific article published on December 5, 1992

Dual percutaneous mechanical circulatory support as a bridge to recovery in fulminant myocarditis

scientific article published on 01 September 2011

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy

scientific article published on 01 January 1992

Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome Era ⬇️

scientific article published on February 15, 2012

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

article

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

scientific article published on 6 July 2021

Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes

scientific article published in 1999

Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

scientific article

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy

scientific article published on 01 October 2001

Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline

scientific article published on 19 March 2018

Genetic cardiomyopathies.

scientific article published on 19 March 2018

Genetic testing in cardiovascular medicine: current landscape and future horizons.

scientific article published on May 2013

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

scientific article published on August 2011

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

scientific article published on August 2011

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM)

scientific article published in May 2021

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.

scientific article

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

scientific article published in February 2012

Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype

scientific article published in December 2017

Late infection in cardiac allograft recipients: profiles, incidence, and outcome

scientific article published on 01 May 1991

Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors ⬇️

scientific article published on 01 August 1991

Managed Care and Outcomes of Hospitalization Among Elderly Patients With Congestive Heart Failure ⬇️

scientific article published on June 8, 1998

Mechanism of Action of Bucindolol in Human Ventricular Myocardium ⬇️

scientific article published on June 1, 1990

Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees

scientific article published on 01 July 2018

Next-generation sequencing to identify genetic causes of cardiomyopathies ⬇️

scientific article published on May 1, 2012

Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain

scientific article published on 16 April 2015

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education.

scientific article published on 9 March 2018

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

scientific article published on May 2009

Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy

scientific article published on 01 May 1992

Rare variant mutations identified in pediatric patients with dilated cardiomyopathy ⬇️

scientific article published on January 1, 2011

Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

scientific article

Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

article

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids

scientific article published on 01 March 1992

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

scientific article published on 01 March 2019

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

scientific article

Return of genetic results in the familial dilated cardiomyopathy research project

scientific article published on 11 August 2012

SCN5A Rare Variants in Familial Dilated Cardiomyopathy Decrease Peak Sodium Current Depending on the Common Polymorphism H558R and Common Splice Variant Q1077del ⬇️

scientific article published on December 1, 2010

Squamous and basal cell carcinoma in heart transplant recipients

scientific article published on June 1, 1998

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

scientific article published on April 2013

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy

scientific article

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

scientific article published in December 2017

Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy ⬇️

scientific article published on April 19, 2011

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

scientific article published on 01 April 2012

Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

scientific article published on 01 June 2018

Vasoactive intestinal peptide in canine hearts: effect of total cardiac denervation

scientific article published on February 1, 1992

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.

scientific article published on July 2012

List of works by Ray E Hershberger

A novel TTN deletion in a family with skeletal myopathy, facial weakness, and dilated cardiomyopathy

A novel human R25C-phospholamban mutation is associated with super-inhibition of calcium cycling and ventricular arrhythmia

Acute decompensated heart failure: update on new and emerging evidence and directions for future research

Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee

Assessment of LMNA Copy Number Variation in 58 Probands with Dilated Cardiomyopathy ⬇️

Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation

Clinical Application of Genetic Testing in Heart Failure.

Clinical Genetic Testing for Familial Hypercholesterolemia

Clinical Outcomes, Quality of Life, and Cost Outcomes After Cardiac Transplantation

Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals ⬇️

Considering complexity in the genetic evaluation of dilated cardiomyopathy

Dilated cardiomyopathy

Dilated cardiomyopathy: the complexity of a diverse genetic architecture.

Dopaminergic inhibition of DNA synthesis in pituitary tumor cells is associated with phosphotyrosine phosphatase activity ⬇️

Dual percutaneous mechanical circulatory support as a bridge to recovery in fulminant myocarditis

Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy

Evaluating Pathogenicity of Rare Variants From Dilated Cardiomyopathy in the Exome Era ⬇️

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy

Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes

Functional characterization of TNNC1 rare variants identified in dilated cardiomyopathy.

Genetic Counseling and Screening Issues in Familial Dilated Cardiomyopathy

Genetic Evaluation of Cardiomyopathy - a Heart Failure Society of America Practice Guideline

Genetic cardiomyopathies.

Genetic testing in cardiovascular medicine: current landscape and future horizons.

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM)

Identification of novel mutations in RBM20 in patients with dilated cardiomyopathy.

Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee

Is Left Ventricular Noncompaction a Trait, Phenotype, or Disease? The Evidence Points to Phenotype

Late infection in cardiac allograft recipients: profiles, incidence, and outcome

Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors ⬇️

Managed Care and Outcomes of Hospitalization Among Elderly Patients With Congestive Heart Failure ⬇️

Mechanism of Action of Bucindolol in Human Ventricular Myocardium ⬇️

Multigenic Disease and Bilineal Inheritance in Dilated Cardiomyopathy Is Illustrated in Nonsegregating LMNA Pedigrees

Next-generation sequencing to identify genetic causes of cardiomyopathies ⬇️

Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain

Pilot Randomized Controlled Trial to Reduce Readmission for Heart Failure Using Novel Tablet and Nurse Practitioner Education.

Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.

Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy

Rare variant mutations identified in pediatric patients with dilated cardiomyopathy ⬇️

Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Reappraisal of Reported Genes for Sudden Arrhythmic Death: An Evidence-Based Evaluation of Gene Validity for Brugada Syndrome

Recurrence of sarcoidosis in a cardiac allograft: control with augmented corticosteroids

Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy

Research priorities in hypertrophic cardiomyopathy: report of a Working Group of the National Heart, Lung, and Blood Institute.

Return of genetic results in the familial dilated cardiomyopathy research project

SCN5A Rare Variants in Familial Dilated Cardiomyopathy Decrease Peak Sodium Current Depending on the Common Polymorphism H558R and Common Splice Variant Q1077del ⬇️

Squamous and basal cell carcinoma in heart transplant recipients

Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy.

The Rationale and Timing of Molecular Genetic Testing for Dilated Cardiomyopathy

Toward Genetics-Driven Early Intervention in Dilated Cardiomyopathy: Design and Implementation of the DCM Precision Medicine Study.

Update 2011: Clinical and Genetic Issues in Familial Dilated Cardiomyopathy ⬇️

Update on Aldosterone Antagonists Use in Heart Failure With Reduced Left Ventricular Ejection Fraction Heart Failure Society of America Guidelines Committee

Variants of Uncertain Significance: Should We Revisit How They Are Evaluated and Disclosed?

Vasoactive intestinal peptide in canine hearts: effect of total cardiac denervation

Where genome meets phenome: rationale for integrating genetic and protein biomarkers in the diagnosis and management of dilated cardiomyopathy and heart failure.